These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 19947989)

  • 1. Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection.
    Enomoto T; Azuma A; Kohno A; Kaneko K; Saito H; Kametaka M; Usuki J; Gemma A; Kudoh S; Nakamura S
    Respirology; 2010 Jan; 15(1):126-31. PubMed ID: 19947989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
    Su YS; Lu JJ; Perng CL; Chang FY
    J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
    ; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
    Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.
    Hardak E; Neuberger A; Yigla M; Berger G; Finkelstein R; Sprecher H; Oren I
    Respirology; 2012 May; 17(4):681-6. PubMed ID: 22390188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome and predictors of survival in patients with pneumocystis jirovecii pneumonia--results of a tertiary referral centre.
    Roembke F; Heinzow HS; Gosseling T; Heinecke A; Domagk D; Domschke W; Meister T
    Clin Respir J; 2014 Jan; 8(1):86-92. PubMed ID: 23848504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection.
    Mansharamani NG; Balachandran D; Vernovsky I; Garland R; Koziel H
    Chest; 2000 Sep; 118(3):712-20. PubMed ID: 10988193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic scoring tool for identification of patients at high and low risk of death from HIV-associated Pneumocystis jirovecii pneumonia.
    Armstrong-James D; Copas AJ; Walzer PD; Edwards SG; Miller RF
    Int J STD AIDS; 2011 Nov; 22(11):628-34. PubMed ID: 22096046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group.
    Stansell JD; Osmond DH; Charlebois E; LaVange L; Wallace JM; Alexander BV; Glassroth J; Kvale PA; Rosen MJ; Reichman LB; Turner JR; Hopewell PC
    Am J Respir Crit Care Med; 1997 Jan; 155(1):60-6. PubMed ID: 9001290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the relationship between absolute lymphocyte count and CD4 count to improve earlier consideration of pneumocystis pneumonia in HIV-positive emergency department patients with pneumonia.
    Napoli AM; Maughan B; Murray R; Maloy K; Milzman D
    J Emerg Med; 2013 Jan; 44(1):28-35. PubMed ID: 22819682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004.
    Overgaard UM; Helweg-Larsen J
    Scand J Infect Dis; 2007; 39(6-7):589-95. PubMed ID: 17577823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia.
    Gingo MR; Lucht L; Daly KR; Djawe K; Palella FJ; Abraham AG; Bream JH; Witt MD; Kingsley LA; Norris KA; Walzer PD; Morris A
    J Acquir Immune Defic Syndr; 2011 Jul; 57(3):190-6. PubMed ID: 21372726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumocystis carinii pneumonia in HIV-infected patients examined by bronchoscopy during the period 1989-1991].
    Jensen AM; Lundgren JD; Nielsen TL; Benfield TL; Vestbo J
    Ugeskr Laeger; 1994 Jul; 156(29):4241-4. PubMed ID: 8066923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review.
    Wu AK; Cheng VC; Tang BS; Hung IF; Lee RA; Hui DS; Yuen KY
    BMC Infect Dis; 2004 Dec; 4(1):57. PubMed ID: 15588295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure.
    Choi JS; Lee SH; Leem AY; Song JH; Kim SY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
    PLoS One; 2018; 13(10):e0206231. PubMed ID: 30359436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection.
    Kim SJ; Lee J; Cho YJ; Park YS; Lee CH; Yoon HI; Lee SM; Yim JJ; Lee JH; Yoo CG; Lee CT; Kim YW; Han SK; Kim HB; Park JS
    J Infect; 2014 Jul; 69(1):88-95. PubMed ID: 24607411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia in HIV-uninfected immunocompromised patients with pulmonary infiltrates.
    Nakashima K; Aoshima M; Ohkuni Y; Hoshino E; Hashimoto K; Otsuka Y
    J Infect Chemother; 2014 Dec; 20(12):757-61. PubMed ID: 25187511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of pneumocystis carinii pneumonia in AIDS patients].
    Armbruster C; Hassl A; Kriwanek S
    Wien Klin Wochenschr; 1998 Sep; 110(17):604-7. PubMed ID: 9816629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
    Blount RJ; Jarlsberg LG; Daly KR; Worodria W; Davis JL; Cattamanchi A; Djawe K; Andama A; Koch J; Walzer PD; Huang L;
    PLoS One; 2012; 7(12):e51545. PubMed ID: 23284710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.